← Leaderboards
David A Bennett
Rush University Medical Center
$145,760,843
Attributed
$179,077,378
Total exposure
36
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $24.3M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$231,694,484 · 39
By mechanism
R01$92,290,273 · 6
P30$74,643,615 · 19
U01$35,737,925 · 3
RF1$22,724,985 · 5
U54$3,708,714 · 1
RC2$998,322 · 1
Top collaborators
- Philip L De Jager23 shared
- Allan I Levey10 shared
- Daniel H Geschwind9 shared
- Thomas J Montine9 shared
- John Q. Trojanowski9 shared
- Juan Troncoso9 shared
- Jinying Zhao8 shared
- Bing Yao5 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Julie A Schneider$29,310,501
- Patricia A Boyle$20,473,928
- Denis A Evans$50,998,326
- Lisa L Barnes$44,877,971
- Zoe Arvanitakis$13,794,895
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainS DiseaseAgingDementiaNeuropathologyCommunitiesResourcesFundingPathologicAutopsyPathologyParticipantImpaired CognitionReligion And SpiritualityPersonsLinkInnovationRisk FactorsMemoryMolecularGenomicsResearch PersonnelBase
Grant awards (200)
Development of Human Microphysiological Systems for Testing of AD/ADRD Interventional Strategies across Genetically Diverse Populations$3,708,714
U54 · FY2025 · AG
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil$3,251,970
R01 · FY2025 · AG · contact PI
Core H: Religious Orders Study Core$706,500
P30 · FY2025 · AG · contact PI
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil$679,014
R01 · FY2025 · AG · contact PI
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations$595,108
R33 · FY2025 · AG
Core A: Administrative Core$266,115
P30 · FY2025 · AG · contact PI
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil$3,731,942
R01 · FY2024 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$2,868,751
R01 · FY2024 · AG · contact PI
Core H: Religious Orders Study Core$706,500
P30 · FY2024 · AG · contact PI
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations$312,880
R61 · FY2024 · AG
Core A: Administrative Core$266,115
P30 · FY2024 · AG · contact PI
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil$3,671,787
R01 · FY2023 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$2,989,007
R01 · FY2023 · AG · contact PI
Core H: Religious Orders Study Core$706,500
P30 · FY2023 · AG · contact PI
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations$321,009
R61 · FY2023 · AG
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain$283,568
R01 · FY2023 · AG
Core A: Administrative Core$266,115
P30 · FY2023 · AG · contact PI
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies$1
R01 · FY2023 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$2,998,331
R01 · FY2022 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$2,950,095
R01 · FY2022 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$2,728,790
U01 · FY2022 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies$2,292,833
R01 · FY2022 · AG · contact PI
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain$713,789
R01 · FY2022 · AG
Core H: Religious Orders Study Core$706,500
P30 · FY2022 · AG · contact PI
Integration of immune cell subtypes across diseases & tissue$405,000
U01 · FY2022 · AG
Core A: Administrative Core$266,115
P30 · FY2022 · AG · contact PI
A shared foundation for single genetic investigations of immune responses$155,483
U01 · FY2022 · AG
Rush Alzheimer's Disease Research Center$3,127,708
P30 · FY2021 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$3,008,531
R01 · FY2021 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$2,884,209
R01 · FY2021 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$2,242,312
U01 · FY2021 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies$2,211,865
R01 · FY2021 · AG · contact PI
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain$732,915
R01 · FY2021 · AG
Core H: Religious Orders Study Core$706,500
P30 · FY2021 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$416,605
U01 · FY2021 · AG
Core A: Administrative Core$266,115
P30 · FY2021 · AG · contact PI
Rush Alzheimer's Disease Core Center$3,522,718
P30 · FY2020 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$3,049,965
U01 · FY2020 · AG
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$3,035,766
R01 · FY2020 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$2,603,054
R01 · FY2020 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$1,215,000
U01 · FY2020 · AG
Core G: Religious Orders Study Core$757,506
P30 · FY2020 · AG · contact PI
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain$745,855
R01 · FY2020 · AG
Rush Alzheimer's Disease Core Center$348,578
P30 · FY2020 · AG · contact PI
Core A: Administrative Core$288,257
P30 · FY2020 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$181,181
U01 · FY2020 · AG
Rush Alzheimer's Disease Core Center$3,503,322
P30 · FY2019 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$2,825,827
R01 · FY2019 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$2,104,828
R01 · FY2019 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$1,648,575
U01 · FY2019 · AG
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain$791,495
R01 · FY2019 · AG
Core G: Religious Orders Study Core$757,896
P30 · FY2019 · AG · contact PI
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer?sDisease$340,882
RF1 · FY2019 · AG
Core A: Administrative Core$288,406
P30 · FY2019 · AG · contact PI
Rush Alzheimer's Disease Core Center$3,352,346
P30 · FY2018 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,952,898
R01 · FY2018 · AG · contact PI
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets$1,668,072
U01 · FY2018 · AG
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,619,042
U01 · FY2018 · AG
Core G: Religious Orders Study Core$692,945
P30 · FY2018 · AG · contact PI
Deconstructing and modeling the single cell architecture of the Alzheimer brain$405,000
RF1 · FY2018 · AG
Rush Alzheimer's Disease Core Center$307,502
P30 · FY2018 · AG · contact PI
Core A: Administrative Core$263,689
P30 · FY2018 · AG · contact PI
Core-007$247,776
P30 · FY2018 · AG · contact PI
Rush Alzheimer's Disease Core Center$164,144
P30 · FY2018 · AG · contact PI
Deconstructing and modeling the single cell architecture of the Alzheimer brain$3,591,103
RF1 · FY2017 · AG
Brain - Plasma Proteomics Biomarker Discovery and Validation in the US and UK$3,174,907
RF1 · FY2017 · AG
Rush Alzheimer's Disease Core Center$2,702,350
P30 · FY2017 · AG · contact PI
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies$2,268,369
R01 · FY2017 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$2,032,810
U01 · FY2017 · AG
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,959,843
R01 · FY2017 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,631,705
U01 · FY2017 · AG
Core G: Religious Orders Study Core$692,946
P30 · FY2017 · AG · contact PI
Rush Alzheimer's Disease Core Center$414,373
P30 · FY2017 · AG · contact PI
Core A: Administrative Core$314,210
P30 · FY2017 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease - Supplement$156,336
U01 · FY2017 · AG
Discovery of Novel Proteomic Targets in Alzheimer's Disease$156,000
U01 · FY2017 · AG
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$5,523,657
RF1 · FY2016 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$3,789,650
U01 · FY2016 · AG
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer?sDisease$3,721,756
RF1 · FY2016 · AG
Rush Alzheimer's Disease Core Center$2,700,313
P30 · FY2016 · AG · contact PI
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies$2,106,031
R01 · FY2016 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$2,096,988
R01 · FY2016 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$1,572,897
U01 · FY2016 · AG
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,541,709
U01 · FY2016 · AG
Core G: Religious Orders Study Core$692,946
P30 · FY2016 · AG · contact PI
Core A: Administrative Core$263,688
P30 · FY2016 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$160,872
U01 · FY2016 · AG
Pathway discovery, validation and compound identification for Alzheimer's disease$153,950
U01 · FY2016 · AG
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimerâs Disease$7,711
RF1 · FY2016 · AG
Pathway discovery, validation and compound identification for Alzheimer's disease$2,162,184
U01 · FY2015 · AG
Rush Alzheimer's Disease Core Center$2,086,279
P30 · FY2015 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,967,107
R01 · FY2015 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,516,903
U01 · FY2015 · AG
Religious Orders Study Core$797,070
P30 · FY2015 · AG · contact PI
Rush Alzheimer's Disease Core Center$507,081
P30 · FY2015 · AG · contact PI
Clinical Core$415,976
P30 · FY2015 · AG · contact PI
Data Management and Statistics Core$308,774
P30 · FY2015 · AG · contact PI
Education and Information Transfer Core$305,828
P30 · FY2015 · AG · contact PI
Administrative Core$258,631
P30 · FY2015 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$178,752
U01 · FY2015 · AG
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$132,600
U01 · FY2015 · AG
Risk Factors, Pathology, and Clinical Expressions of AD$5,959,969
RF1 · FY2014 · AG · contact PI
Rush Alzheimer's Disease Core Center$2,162,153
P30 · FY2014 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$2,048,949
R01 · FY2014 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$1,771,130
U01 · FY2014 · AG
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,530,583
U01 · FY2014 · AG
Religious Orders Study Core$745,050
P30 · FY2014 · AG · contact PI
Neuropathology Core$406,814
P30 · FY2014 · AG · contact PI
Clinical Core$367,073
P30 · FY2014 · AG · contact PI
Data Management and Statistics Core$272,423
P30 · FY2014 · AG · contact PI
Administrative Core$213,711
P30 · FY2014 · AG · contact PI
Education and Information Transfer Core$157,082
P30 · FY2014 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$154,995
R01 · FY2014 · AG · contact PI
Rush Alzheimer's Disease Core Center$153,000
P30 · FY2014 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$114,934
U01 · FY2014 · AG
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$110,684
U01 · FY2014 · AG
Rush Alzheimer's Disease Core Center$2,032,558
P30 · FY2013 · AG · contact PI
Pathway discovery, validation and compound identification for Alzheimer's disease$1,694,201
U01 · FY2013 · AG
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$738,972
R01 · FY2013 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$713,280
R01 · FY2013 · AG · contact PI
Religious Orders Study Core$699,902
P30 · FY2013 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$519,864
R01 · FY2013 · AG · contact PI
Neuropathology Core$383,206
P30 · FY2013 · AG · contact PI
Clinical Core$345,361
P30 · FY2013 · AG · contact PI
Data Management and Statistics Core$255,588
P30 · FY2013 · AG · contact PI
Administrative Core$200,565
P30 · FY2013 · AG · contact PI
Education and Information Transfer Core$147,936
P30 · FY2013 · AG · contact PI
Rush Alzheimer's Disease Core Center$2,183,451
P30 · FY2012 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,684,096
R01 · FY2012 · AG · contact PI
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$815,654
R01 · FY2012 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$788,428
R01 · FY2012 · AG · contact PI
Religious Orders Study Core$751,626
P30 · FY2012 · AG · contact PI
Neuropathology Core$412,660
P30 · FY2012 · AG · contact PI
Clinical Core$371,454
P30 · FY2012 · AG · contact PI
Data Management and Statistics Core$273,265
P30 · FY2012 · AG · contact PI
Administrative Core$215,171
P30 · FY2012 · AG · contact PI
Education and Information Transfer Core$159,275
P30 · FY2012 · AG · contact PI
Rush Alzheimer's Disease Core Center$2,193,284
P30 · FY2011 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,666,519
R01 · FY2011 · AG · contact PI
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$836,996
R01 · FY2011 · AG · contact PI
Religious Orders Study Core$755,013
P30 · FY2011 · AG · contact PI
Neuropathology Core$415,667
P30 · FY2011 · AG · contact PI
Clinical Core$373,710
P30 · FY2011 · AG · contact PI
Data Management and Statistics Core$273,264
P30 · FY2011 · AG · contact PI
Administrative Core$215,924
P30 · FY2011 · AG · contact PI
Education and Information Transfer Core$159,706
P30 · FY2011 · AG · contact PI
Rush Alzheimer's Disease Core Center$2,059,814
P30 · FY2010 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,663,638
R01 · FY2010 · AG · contact PI
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$836,451
R01 · FY2010 · AG · contact PI
CORE--RELIGIOUS ORDERS STUDY$799,465
P30 · FY2010 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$793,219
R01 · FY2010 · AG · contact PI
Cognitive Decline and Dementia: Life Experiences and the Brain Histone Epigenome$498,323
RC2 · FY2010 · AG · contact PI
Rush Alzheimer's Disease Core Center$2,011,724
P30 · FY2009 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,615,537
R01 · FY2009 · AG · contact PI
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences$827,440
R01 · FY2009 · AG · contact PI
CORE--RELIGIOUS ORDERS STUDY$768,297
P30 · FY2009 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$677,729
R01 · FY2009 · AG · contact PI
Cognitive Decline and Dementia: Life Experiences and the Brain Histone Epigenome$499,999
RC2 · FY2009 · AG · contact PI
Degraded Rationality: Subclinical Neuropathology and Neuroeconomic Behavior in Ol$58,016
R21 · FY2009 · AG · contact PI
Rush Alzheimer's Disease Core Center$1,955,459
P30 · FY2008 · AG · contact PI
Epidemiologic Study of Neural Reserve and Neurobiology of Aging$1,607,814
R01 · FY2008 · AG · contact PI
CORE--RELIGIOUS ORDERS STUDY$732,922
P30 · FY2008 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$693,242
R01 · FY2008 · AG · contact PI
Degraded Rationality: Subclinical Neuropathology and Neuroeconomic Behavior in Ol$72,520
R21 · FY2008 · AG · contact PI
Rush Alzheimer's Disease Core Center$1,930,180
P30 · FY2007 · AG · contact PI
CORE--RELIGIOUS ORDERS STUDY$773,112
P30 · FY2007 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$599,328
R01 · FY2007 · AG · contact PI
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$444,000
R01 · FY2007 · AG · contact PI
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$147,782
R01 · FY2007 · AG · contact PI
Rush Alzheimer's Disease Core Center$146,162
P30 · FY2007 · AG · contact PI
Degraded Rationality: Subclinical Neuropathology and Neuroeconomic Behavior in Ol$74,000
R21 · FY2007 · AG · contact PI
Rush Alzheimer's Disease Core Center$1,925,131
P30 · FY2006 · AG · contact PI
Risk Factors, Pathology, and Clinical Expressions of AD$605,948
R01 · FY2006 · AG · contact PI
CORE--RELIGIOUS ORDERS STUDY$443,705
P30 · FY2006 · AG · contact PI
ADMINISTRATIVE CORE$131,307
P30 · FY2006 · AG · contact PI
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$1,955,194
R01 · FY2005 · AG
Rush Alzheimer's Disease Core Center$1,881,224
P30 · FY2005 · AG
Risk Factors, Pathology, and Clinical Expressions of AD$617,805
R01 · FY2005 · AG
Rush Alzheimer's Disease Core Center$38,640
P30 · FY2005 · AG
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$1,903,568
R01 · FY2004 · AG
Rush Alzheimer's Disease Core Center$1,837,081
P30 · FY2004 · AG
Risk Factors, Pathology, and Clinical Expressions of AD$637,669
R01 · FY2004 · AG
Rush Alzheimer's Disease Core Center$2,000
P30 · FY2004 · AG
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$1,854,781
R01 · FY2003 · AG
Rush Alzheimer's Disease Core Center$1,811,357
P30 · FY2003 · AG
Risk Factors, Pathology, and Clinical Expressions of AD$655,038
R01 · FY2003 · AG
Rush Alzheimer's Disease Core Center$96,079
P30 · FY2003 · AG
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$1,768,720
R01 · FY2002 · AG
Rush Alzheimer's Disease Core Center$1,752,381
P30 · FY2002 · AG
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF AD$394,801
R01 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE--RELIGIOUS STUDY$178,517
P30 · FY2002 · AG
CORE--RELIGIOUS STUDY$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGING$1,449,264
R01 · FY2001 · AG
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF AD$403,935
R01 · FY2001 · AG
CORE--RELIGIOUS ORDERS STUDY$0
P30 · FY2001 · AG
CORE--CLINICAL$0
P30 · FY2001 · AG
CORE--RELIGIOUS STUDY$0
P30 · FY2001 · AG
CORE-- CLINICAL$0
P30 · FY2001 · AG